000			01930 a2200541 4500
005			20250515034654.0
264		0	_c20061024
008			200610s 0 0 eng d
022			_a0007-1188
024	7		_a10.1038/sj.bjp.0706823 _2doi
040			_aNLM _beng _cNLM
100	1		_aLalu, M M
245	0	0	_aMatrix metalloproteinases contribute to endotoxin and interleukin-1beta induced vascular dysfunction. _h[electronic resource]
260			_bBritish journal of pharmacology _cSep 2006
300			_a31-42 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAorta, Thoracic
650	0	4	_aBlotting, Western
650	0	4	_aCollagenases _xmetabolism
650	0	4	_aEndotoxemia _xenzymology
650	0	4	_aEndotoxins _xblood
650	0	4	_aGelatinases _xmetabolism
650	0	4	_aIn Vitro Techniques
650	0	4	_aInterleukin-1 _xtoxicity
650	0	4	_aMale
650	0	4	_aMatrix Metalloproteinases _xmetabolism
650	0	4	_aMuscle Contraction _xdrug effects
650	0	4	_aMuscle Proteins _xmetabolism
650	0	4	_aMuscle Tonus _xdrug effects
650	0	4	_aMuscle, Smooth, Vascular _xdrug effects
650	0	4	_aNitrates _xblood
650	0	4	_aNitrites _xblood
650	0	4	_aPhenylephrine _xpharmacology
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aTissue Inhibitor of Metalloproteinase-1 _xmetabolism
650	0	4	_aTissue Inhibitor of Metalloproteinases _xmetabolism
650	0	4	_aVascular Diseases _xchemically induced
650	0	4	_aVasoconstrictor Agents _xpharmacology
650	0	4	_aTissue Inhibitor of Metalloproteinase-4
700	1		_aCena, J
700	1		_aChowdhury, R
700	1		_aLam, A
700	1		_aSchulz, R
773	0		_tBritish journal of pharmacology _gvol. 149 _gno. 1 _gp. 31-42
856	4	0	_uhttps://doi.org/10.1038/sj.bjp.0706823 _zAvailable from publisher's website
999			_c16469520 _d16469520